Table of Contents Table of Contents
Previous Page  430 / 1096 Next Page
Information
Show Menu
Previous Page 430 / 1096 Next Page
Page Background

S415

ESTRO 36

_______________________________________________________________________________________________

Results

The detector presents dependency on energy that is

reflected in the response variation with depth and field

size (2.2% under-response for 6 MV, 20x20 cm

2

at 20 cm

depth).

The anisotropy study shows important deviations: 28% for

lateral incidences and 7% for posterior incidence.

The detector sensitivity for leaf positioning measurement

is 1.8 % per tenth of millimeter in the penumbra.

The output factor corresponding to 6 MV and 1x1 cm

2

shows +2% deviation compared with the measurements

obtained using a SFD diode and a CC13 gas ionization

chamber. The results are normalized to a 5x5 cm

2

. For a

10x10 cm

2

this deviation is -1%. If the energy increases the

deviations decrease (+1% for 1x1 cm

2

and -0.5% for 10x10

cm

2

in 10 MV and 15 MV).

In the measurement of small field profiles the gamma

comparison between measurements with the liquid

ionization array and radiographic film shows 100% passing

rates with tolerances 1% - 1mm.

Several patient treatments have been verified. In table 1

the comparison between the treatment planning system

and the array measurement for a particular case is shown.

We show differences in gamma passing rates when

anisotropy corrections are applied or not. Figure 1 shows

one of such comparisons.

Conclusion

A new detector array is presented for the verification of

patient treatments of high complexity.

The detector presents a small dependence on

energy, which causes a small over-response for the output

factors of small fields and an under-response for output

factors of large fields. The anisotropy of the device is

significant (28% and 7% for lateral and posterior

incidences), but can be compensated during treatment

verification by using angle-dependent correction factors.

The usefulness for the patient treatment verification has

been demonstrated by measuring different patient

treatments. The results obtained confirm the validity of

this array for dose distribution measurements of complex

treatments with small fields and high gradients.

PO-0783 Planverification in Robotic Stereotactic

Radiotherapy with the Delta4-Dosimetry-System

W. Baus

1

, G. Altenstein

1

1

Universität zu Köln, Department of Medical Physics,

Köln, Germany

Purpose or Objective

Stereotactic robotic radiotherapy with the CyberKnife

(Accuray, Sunnyvale) might not be fluency modulated

radiotherapy (IMRT) in the strict sense. However, the

technique is comparable in complexity because of a large

number of small (5 to 60 mm), highly non-coplanar fields.

Therefore, the manufacturer recommends individual plan

verification (DQA, Delivery Quality Assurance), though

only on a point dose measurement basis. The report of the

AAPM task group on robotic radiotherapy (TG 135) [1]

advises the use of film. However, because film dosimetry

is rather cumbersome in most cases, it foregoes to demand

it for every plan. Film dosimetry provides 2D-

measurement, but also laborious calibration, fading and

non-linear sensitivity. Arrays of dosemeters have the

advantage of comparably easy and direct evaluation,

though at a distinctively lower resolution. The aim of this

work is to investigate the usefulness of an existing

dosimetry system based on diode arrays – the Delta4+

Phantom (ScandiDos, Uppsala) – for DQA of the CyberKnife

robotic treatment system.

Material and Methods

Several patient plans with PTVs ranging from 5.6 to 112

cm³ were investigated. The irradiation was performed

with a CyberKnife (G4, rel. 9.5, 6 MV photons, no

flattening filter), treatment planning system was

Multiplan (rel. 4.5). The Delta4+ dosimetry system consists

of a PMMA-cylinder of 22 cm diameter in which two

orthogonal silicon diode arrays are housed, adjecent to

electrometers. There are 1069 detectors, an inner region

with detector spacing of 5 mm (6x6 cm²) and 10 mm

spacing in the outer region. The measurements were

carried out with software Vers. 2015/10. The

measurements were compared to film (Gafchromic EBT3

Film, ISP, Wayne) and a high-resolution ion chamber array

(Octavius 1000 SRS, PTW, Freiburg). A speciality of the

CyberKnife treatment is the fact that correct image

guided positioning – using X-ray opaque markers, e.g. – is

mandatory. Therefore, special considerations have to be

taken for marker placement.

Results

Positioning and localisation of the Delta4 was possible and

the plan verification could be carried out. The evaluation

with the scandidos software produced results with good

agreement between plan and measurement (see fig. 1).

The evaluation was somewhat compromised by system

breakdowns (maybe caused by treatment times of

typ.an

hour) and the non-complanarity of the plans which

prevented the correction for gantry angle usually

exploited by the software.

The scandidos software allows for a 3-dimensional

evaluation of the dose distribution. The lower spacial

resolution compared to film or the 1000 SRS seems to be

less important, on the other hand.

Conclusion

In principle, the Delta4 dosimetry system seems to be

highly suited for DQA of CyberKnife treatment. However,

the manufacturer should improve the system in terms of

radiaton resistance and a proper implementation of

fiducial markers to make it wholly suitable for Cyberknife

DQA.

[1] S. Dieterich et al., Report of AAPM TG 135, Med. Phys.

2011

PO-0784 Volume correction factors for alanine

dosimetry in small MV photon fields

H.L. Riis

1

, S.J. Zimmermann

1

, J. Helt-Hansen

2

, C.E.

Andersen

2

1

Odense University Hospital, Department of Oncology,

Odense, Denmark

2

Technical University of Denmark, Center for Nuclear

Technologies, Roskilde, Denmark

Purpose or Objective

Alanine is a passive solid-state dosimeter material with

potential applications for remote auditing and dosimetry

in complex fields or non-reference conditions. Alanine has

a highly linear dose response which is essentially

independent of dose rate and energy for clinical MV

photon beams. Alanine is available as pellets with a 5 mm

diameter, and irradiations in flattening filter-free

(FFF) beams or other non-uniform beams are therefore

subject to volume averaging. In this work, we report on a

simple model that can provide volume correction factor

for improved output factor measurements in small MV

photon beams.

Material and Methods

The x-ray beam was delivered by an Elekta Versa HD linac

with an Agility MLC160 radiation head. Square field sizes

(FS) 0.8, 1.0, 1.4, 2.0, 3.0, 4.0, 5.0, 7.0, 10.0, 20.0, 30.0,

40.0 cm were investigated. The data were acquired at

SSD=90 cm, depth 10 cm. The alanine pellets were the

standard Harwell/NPL type (Ø4.83×2.80 mm). The pellets

were placed in water with a latex sleeve to protect against

water. A Bruker EMX-micro EPR spectrometer equipped

with an EMX X-band high sensitivity resonator was used to

read out the dose deposited in the alanine pellets. The

horizontal beam profiles were measured using the IBA

Dosimetry photon field detector (PFD) for all FSs while

depth dose profiles were measured using the PTW

microLion (FS < 8 cm) and PTW semiflex (FS > 8 cm)